Status:

COMPLETED

Study on the Effects of Wheat and Corn Germ Blend Oil on Antioxidation and Immune Regulation of Dyslipidemia Population

Lead Sponsor:

Southeast University, China

Collaborating Sponsors:

Chinese Nutrition Society

Zhongda Hospital

Conditions:

Metabolic Diseases

Immune System Disorder

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The goal of this clinical trial is to explore the role of wheat and corn germ blended oils in regulating oxidative stress and immunomodulation in dyslipidaemic populations, to explore their effects on...

Detailed Description

The design of this intervention trial was a randomised controlled trial, in which the included dyslipidaemic population was randomly divided into a wheat corn germ blended oil intervention group and a...

Eligibility Criteria

Inclusion

  • Male or female aged 18-65 with BMI less than 30;
  • At least one item meets the diagnostic criteria for dyslipidemia (2016 Chinese adult dyslipidemia prevention and treatment guide)
  • No serious complications related to liver, kidney, digestive tract, endocrine diseases and chronic diseases;
  • Within 3 months, he did not use the drugs and dietary supplements related to reducing blood fat and weight, and agreed not to use the above foods or drugs during the experiment;
  • Volunteer to participate in this study after listening to the project introduction and sign the informed consent form.

Exclusion

  • Pregnant, pregnant or lactating women;
  • Patients with liver and kidney dysfunction, diabetes, coronary heart disease, hyperthyroidism, malignant tumor, asthma and other chronic diseases other than dyslipidemia;
  • Endocrine disease patients, postoperative patients, patients receiving hormone therapy and psychotic patients;
  • Have special eating habits: vegetarian, ketogenic diet (high fat, low carbon water), etc;
  • Those who cannot follow the test requirements.

Key Trial Info

Start Date :

March 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2023

Estimated Enrollment :

102 Patients enrolled

Trial Details

Trial ID

NCT06060509

Start Date

March 1 2023

End Date

December 1 2023

Last Update

October 15 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Southeast university

Nanjing, Jiangsu, China, 210000